pela Volanek has received lecture honoraria from Novo Nordisk, Eli Lilly, Medtronic, Abbott, AstraZeneca and Boehringer Ingelheim
These sites may offer compounded versions at a discounted price, but the safety of these medications is uncertain as each GLP-1 receptor agonist is only available as a branded medication manufactured by a single company
Laboratory evaluation should assess for metabolic derangements, including electrolyte abnormalities, dehydration, and malnutrition markers
Common symptoms of gastroparesis may include: Bowel obstruction is a condition in which the small intestine or large intestine becomes partially or completely blocked, preventing the normal movement of food, fluids, gas, and waste through the digestive tract
Patients receiving GLP-1 had about 43% lower odds of developing portal hypertension